#telemedicine

There are no hard-and-fast rules, but here’s some guidance about when it may make more sense to choose one or the other.

Patients saved as much as $222 per telehealth visit during the COVID pandemic.

Using smartphones as diagnostic tools is a work in progress, experts say.

Refining algorithms by incorporating more images of people of color can teach AI to better diagnose melanoma and other skin cancers.

Four academic institutions will establish centers of excellence to conduct research on telehealth for cancer-related health care.

A new survey finds that remote technologies to reduce travel and in-person appointments appeal to cancer patients.

However, Black people and uninsured folks with cancer were not as likely to access care via telemedicine.

The ability to receive cancer care through phones and video is changing the experience. But does telehealth worsen health disparities?

Patient surveys show that more people with cancer undergoing radiotherapy prefer telemedicine to in-person visits.

COVID-19 has led to increased use of telemedicine, but it’s not suited for all patients or all situations.

Efforts to reach patients during the COVID-19 pandemic has led to both setbacks and new innovations in cancer screening.

The COVID-19 pandemic has turned virtual health from a niche service into a mainstay of modern medicine. But it’s not working for everyone.

The pandemic raises new concerns, but it may also lead to long-lasting improvements.

Delays in screening, diagnosis and treatment could lead to poorer outcomes.